Converting enzyme activity in human plasma.
نویسندگان
چکیده
Human plasma converting enzyme activity was investigated by comparing biological with immunological activity of added or generated angiotensin after plasma incubation. Sodium citrate (2 X 10" 2 M), 2:2'-dipyridyl (1 X lO 4 and 1 X 10~M), chromotropic acid (3 X 10" and 3 X K H M ) and desferrioxamine (10 and 100 mg/100 ml) did not interfere with converting enzyme. By contrast, EDTA (3 X H H M and 3 X 1 0 " 2 M ) , EGTA (3 X H H M ) , 8quinolinol (1 X 1 0 2 M ) , and oxalic acid (3 X 10~M) were shown to interfere with plasma converting enzyme activity. The EDTA inhibition of converting enzyme activity could be partially reversed by molar excess amounts of calcium, zinc and cobalt. The ability of these ions to restore converting enzyme activity to the plasma was quantitatively variable. Inhibition of converting enzyme activity by EDTA could not be reversed by the addition of iron, copper or manganese to the samples.
منابع مشابه
Renoprotective differences between perindopril and enalapril in the diabetic hypertensive rat do not reflect glomerular angiotensin-converting enzyme activity.
1. The various angiotensin-converting enzyme inhibitors have structural differences which affect their affinities for the catalytic sites on converting enzyme. We postulated that such differences might result in differences in renoprotective efficacy. We investigated this in the diabetic spontaneous hypertensive rat. We also investigated whether these differences might reflect variations in glo...
متن کاملThe host’s angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections
The number of victims of the COVID-19 pandemic shows important geographical differences. In this study, a number of human genetic polymorphisms were compared to the number of Covid-19 patients and Covid-19 mortality. Data from 33 countries were analyzed. Among the polymorphisms tested, the human angiotensine converting enzyme (ACE) polymorphism turned out to be a determinant factor in both prev...
متن کاملAltered angiotensin I conversion in pulmonary disease.
1. A specific method is described for the measurement of angiotensin I converting enzyme activity in plasma with 125 I-labelled angiotensin I used as substrate. 2. Converting enzyme activity in plasma from fifteen normal subjects, eleven patients with sarcoidosis, twelve patients with chronic obstructive pulmonary disease and three patients with shock lung was assayed by this technique. 3. Pati...
متن کاملDiscrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.
Captopril, an inhibitor of angiotensin converting enzyme, was administered twice daily to 13 hypertensive patients for a mean period of 9 weeks. Continuous blood pressure control in the ambulatory patients was established with a portable blood pressure recorder. Notwithstanding, in eight patients with normal renal function, plasma converting enzyme was found to resume normal activity before adm...
متن کاملStudy of Serum and Tissues Angiotensin Converting Enzyme (ACE) Activity in Rat with Gentamicin Induced Renal Toxicity
The angiotensin I-converting enzyme (ACE) converts the inactive angiotensin I molecule to the active angiotensin II. ACE is rich in epithelium, endothelium, and neuroepithelial cells and it found largely on the brush border of intestine and kidney proximal tubules. ACE also presents in the serum. Some pulmonary and renal toxic drugs change the serum and tissue ACE contents. In this research ACE...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Circulation research
دوره 28 2 شماره
صفحات -
تاریخ انتشار 1971